Home / Intelligence / Briefs

Search

Briefs

COVID-19 Briefing Series: Launch in the Age of COVID-19

While COVID-19 is grinding world economies to a potentially disastrous halt, the pharmaceutical and biotech industry continues to move forward at a slower pace. How can companies ensure an agile launch despite the uncertainty and ensure launch success during and in a post-COVID-19 world? Publication Access Form…

Read Now

Briefs

COVID-19 Briefing Series: Telehealth as the New Normal

Highlights from Trinity’s Recent Research Focused on Telehealth Since earlier this year when the COVID-19 virus outbreak began and quickly made its way around the globe, the way in which we operate has changed. Virtual communication for personal as well as business interactions is on the rise. Publication Access Form…

Read Now

Briefs

COVID-19 Briefing Series: European HCP Perspectives

Highlights from Trinity’s Recent Research Focused on European HCP The COVID-19 pandemic continues to have an unprecedented impact on our lives and is disrupting businesses as it spreads worldwide. As the EU5 countries comprise some of the most important pharmaceutical markets, and with Italy, Spain and France includes countries which have been impacted significantly from COVID-19, Trinity aimed to understand the impact on HCP engagement with Market Research. Publication access form…

Read Now

Briefs

COVID-19 Briefing Series: Forecasting Peer Connect

Perspectives from 50+ Industry Forecasting Leaders, Highlights from Trinity’s Recent Research Focused on BioPharma Forecasting In a time of peak uncertainty, forecasters are being called on to answer some of the industry’s toughest questions surrounding the impact of COVID-19. Trinity is bringing together the latest data on challenges forecasters have been experiencing over the past few weeks. This research activity is a joint project of Trinity’s Forecasting Center of Excellence and its benchmarking division, TGaS Advisors. Publication Access Form…

Read Now

Briefs

COVID-19 Briefing Series: Impact of COVID-19 on Healthcare Market Research

The COVID-19 pandemic continues to have an unprecedented impact on our lives and is disrupting businesses as it spreads worldwide. The social distancing measures that are critically important to address the pandemic present new challenges with patient recruitment for clinical trials, market research, and drug launches. In this time of uncertainty, Trinity is assessing the impact on market research services including the ability of healthcare providers to participate in research. In its latest brief, “Impact of COVID-19 on Healthcare Market…

Read Now

Briefs

Making the Leap From Pharma to Pre-Commercial: A Field Guide for the New CCO

By Curt Staab, TGaS® Advisors, a division of Trinity Executive Summary TGaS® Advisors’ Emerging Life Sciences Network (elsN) has gathered advice and lessons learned from a broad-based CCO peer network to create this guide, the first in a series designed to help CCOs manage day-to-day and for the long-term. In this White Paper, we provide an overview of a CCO’s responsibilities, resources and expectations. Future issues will offer advice from peers and experts on launch planning and hiring. To learn more,…

Read Now

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.